Devoid of marketed drugs, investors will focus on Viking Therapeutics' (VKTX) pipeline updates when it reports first-quarter earnings results. Read this story
Devoid of marketed drugs, investors will focus on Viking Therapeutics' (VKTX) pipeline updates when it reports first-quarter earnings results. Read this story
More from Yahoo Finance | Earnings Surprise Viking Therapeutics Inc. Viking NASDAQ:VKTX Finance Nasdaq